NCT02175602 - Study of Drug Combination on Pharmacokinetics in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Conditions

Hepatitis C Infection

Interventions

DRUG

Escitalopram

10 milligrams administered each morning

DRUG

Sertraline

50 milligrams administered each morning

DRUG

DCV 3DAA FDC

Fixed dose combination (daclatasvir \[DCV\] 30 milligrams, asunaprevir \[ASV\] 200 milligrams, and BMS-791325 75 milligrams) one tablet administered twice daily

DRUG

BMS-791325

75 milligrams single-agent film coated oral tablet administered twice daily